# C_2012012EN.01001901.xml

| 14.1.2012 | EN | Official Journal of the European Union | C 12/19 |
| --------- | -- | -------------------------------------- | ------- |

---

Prior notification of a concentration

(Case COMP/M.6438 — Saria/Teeuwissen/Jagero II/Quintet/Bioiberica)

(Text with EEA relevance)

2012/C 12/07

| 1. | On 6 January 2012, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004( 1 ) by which the undertaking Saria Bio-Industries AG & Co. KG (Saria, Germany), belonging to the Rethmann AG & Co. KG (the Rethmann Group, Germany), acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the undertakings Teeuwissen Holding BV (Teeuwissen, the Netherlands), Jagero Holding II, SL (Jagero II, Spain), Quintet Beheer BV (Quintet, the Netherlands) and Bioibérica, SA (Bioibérica, Spain), by way of purchase of shares. |
| -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ |

| 2. | The business activities of the undertakings concerned are:
—
For Saria: collection and processing of animal by-products into protein meals and fats as well as collection and processing of food leftovers to be used as input material for biogas production, —
For Teeuwissen: production of casings and purchasing and processing of abattoir by-products to be used by different industries, —
For Jagero II: holding company owning companies active in the production of casings and the processing of abattoir by-products to be used by different industries, —
For Quintet: holding company with interests in companies with very limited activities in the processing of abattoir by-products outside the EU, —
For Bioibérica: production and commercialization of Active Pharmaceutical Ingredients (APIs.) and pharmaceutical products. | — | For Saria: collection and processing of animal by-products into protein meals and fats as well as collection and processing of food leftovers to be used as input material for biogas production, | — | For Teeuwissen: production of casings and purchasing and processing of abattoir by-products to be used by different industries, | — | For Jagero II: holding company owning companies active in the production of casings and the processing of abattoir by-products to be used by different industries, | — | For Quintet: holding company with interests in companies with very limited activities in the processing of abattoir by-products outside the EU, | — | For Bioibérica: production and commercialization of Active Pharmaceutical Ingredients (APIs.) and pharmaceutical products. |
| -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | - | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | - | ------------------------------------------------------------------------------------------------------------------------------- | - | ------------------------------------------------------------------------------------------------------------------------------------------------------------------ | - | ----------------------------------------------------------------------------------------------------------------------------------------------- | - | -------------------------------------------------------------------------------------------------------------------------- |
| — | For Saria: collection and processing of animal by-products into protein meals and fats as well as collection and processing of food leftovers to be used as input material for biogas production, | | | | | | | | | | |
| — | For Teeuwissen: production of casings and purchasing and processing of abattoir by-products to be used by different industries, | | | | | | | | | | |
| — | For Jagero II: holding company owning companies active in the production of casings and the processing of abattoir by-products to be used by different industries, | | | | | | | | | | |
| — | For Quintet: holding company with interests in companies with very limited activities in the processing of abattoir by-products outside the EU, | | | | | | | | | | |
| — | For Bioibérica: production and commercialization of Active Pharmaceutical Ingredients (APIs.) and pharmaceutical products. | | | | | | | | | | |

| 3. | On preliminary examination, the Commission finds that the notified transaction could fall within the scope the EC Merger Regulation. However, the final decision on this point is reserved. |
| -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |

| 4. | The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.
Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax (+32 22964301), by e-mail to COMP-MERGER-REGISTRY@ec.europa.eu or by post, under reference number COMP/M.6438 — Saria/Teeuwissen/Jagero II/Quintet/Bioiberica, to the following address:
European Commission Directorate-General for Competition Merger Registry J-70 1049 Bruxelles/Brussel BELGIQUE/BELGIË | European Commission | Directorate-General for Competition | Merger Registry | J-70 | 1049 Bruxelles/Brussel | BELGIQUE/BELGIË |
| ----------------------------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------- | ----------------------------------- | --------------- | ---- | ---------------------- | --------------- |
| European Commission | | | | | | | |
| Directorate-General for Competition | | | | | | | |
| Merger Registry | | | | | | | |
| J-70 | | | | | | | |
| 1049 Bruxelles/Brussel | | | | | | | |
| BELGIQUE/BELGIË | | | | | | | |

---

( 1 )  OJ L 24, 29.1.2004, p. 1 (the ‘EC Merger Regulation’).

---